Status:
NOT_YET_RECRUITING
Efficacy of NSAID vs. Steroid-NSAID Combo Post-Selective Laser Trabeculoplasty: Phase 4, Single-Center RCT
Lead Sponsor:
St. Joseph's Healthcare Hamilton
Conditions:
Open Angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This clinical trial, led by Dr. Enitan A. Sogbesan at the Hamilton Regional Eye Clinic, St. Joseph's Healthcare Hamilton, aims to compare the efficacy and safety of non-steroidal anti-inflammatory dru...
Detailed Description
Selective Laser Trabeculoplasty (SLT) is a widely used procedure introduced by Latina and Park in 1995 for the management of various forms of glaucoma, including open-angle glaucoma (OAG), pigmentary ...
Eligibility Criteria
Inclusion
- Adults aged 18 years and older.
- Diagnosed with open-angle glaucoma.
- Intraocular pressure (IOP) greater than 16 mmHg on at least two consecutive occasions separated by one month.
- Visual acuity of 20/200 or better in at least one eye.
- Provided informed consent.
Exclusion
- Patients with any other ocular disorders or surgeries within the last six months.
- Allergy or intolerance to ketorolac or fluorometholone.
- Previous use of systemic ketorolac or fluorometholone in the past month.
- Pregnancy or breastfeeding.
- Patients who are unable to speak/understand English.
- Any condition that in the investigator's opinion would make participation not in the best interest of the patient or could prevent, limit, or confound the protocol-specified assessments.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT06498440
Start Date
September 1 2024
End Date
July 1 2025
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Healthcare Hamilton, Hamilton Regional Eye Institute
Hamilton, Ontario, Canada, L8G 4X3